1,630 results on '"Diehl, Volker"'
Search Results
2. Assessing the efficacy and tolerability of PET-guided BrECADD versus eBEACOPP in advanced-stage, classical Hodgkin lymphoma (HD21): a randomised, multicentre, parallel, open-label, phase 3 trial
3. Tolerability and efficacy of BrECADD versus BEACOPP in advanced stage classical Hodgkin lymphoma: GHSG HD21, a randomized study.
4. Historische Lexikographie des Deutschen: Perspektiven eines Forschungsfeldes im digitalen Zeitalter
5. PET-guided eBEACOPP treatment of advanced-stage Hodgkin lymphoma (HD18): follow-up analysis of an international, open-label, randomised, phase 3 trial
6. Intensified treatment of patients with early stage, unfavourable Hodgkin lymphoma: long-term follow-up of a randomised, international phase 3 trial of the German Hodgkin Study Group (GHSG HD14)
7. PET-guided omission of radiotherapy in early-stage unfavourable Hodgkin lymphoma (GHSG HD17): a multicentre, open-label, randomised, phase 3 trial
8. Follow-up of the GHSG HD16 trial of PET-guided treatment in early-stage favorable Hodgkin lymphoma
9. Relapsed and refractory nodular lymphocyte-predominant Hodgkin lymphoma: an analysis from the German Hodgkin Study Group
10. Intensive treatment strategies in advanced-stage Hodgkin's lymphoma (HD9 and HD12): analysis of long-term survival in two randomised trials
11. Wortwelten: Lexikographie, Historische Semantik und Kulturwissenschaft
12. PET-guided treatment in patients with advanced-stage Hodgkin's lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group
13. Progression-free survival of early interim PET-positive patients with advanced stage Hodgkin's lymphoma treated with BEACOPPescalated alone or in combination with rituximab (HD18): an open-label, international, randomised phase 3 study by the German Hodgkin Study Group
14. Treatment of Advanced-Stage Hodgkin Lymphoma
15. Isolation of Viable Hodgkin and Reed-Sternberg Cells from Hodgkin Disease Tissues
16. Cancer-related fatigue in patients with and survivors of Hodgkin's lymphoma: a longitudinal study of the German Hodgkin Study Group
17. Somatic Mutation of the Cd95 Gene in Human B Cells as a Side-Effect of the Germinal Center Reaction
18. The European Cancer Patient’s Bill of Rights, update and implementation 2016
19. Improving perfusion quantification in arterial spin labeling for delayed arrival times by using optimized acquisition schemes
20. Omission of dacarbazine or bleomycin, or both, from the ABVD regimen in treatment of early-stage favourable Hodgkin's lymphoma (GHSG HD13): an open-label, randomised, non-inferiority trial
21. Treatment Related Morbidity in Patients with Classical Hodgkin Lymphoma: Results of the Ongoing, Randomized Phase III HD21 Trial By the German Hodgkin Study Group
22. Erkrankungen des Blutes
23. Treatment of Advanced Stage Hodgkin Lymphoma
24. P008: Impact of bone marrow involvement on early PET response and progression-free survival in the HD18 trial for patients with advanced-stage Hodgkin lymphoma
25. T002: Treatment related morbidity in patients with classical Hodgkin Lymphoma: results of the ongoing, randomized phase III HD21 Trial by The German Hodgkin Study Group
26. Hodgkin-Lymphom
27. Therapy-related acute myeloid leukemia and myelodysplastic syndromes in patients with Hodgkin lymphoma: a report from the German Hodgkin Study Group
28. Nationales Centrum für Tumorerkrankungen (NCT) Heidelberg
29. Erkrankungen des lymphatischen Systems
30. Effect of initial treatment strategy on survival of patients with advanced-stage Hodgkin's lymphoma: a systematic review and network meta-analysis
31. Morbus Hodgkin
32. Hodgkin’s Disease
33. Treatment Related Morbidity in Patients with Classical Hodgkin Lymphoma: Results of the Ongoing, Randomized Phase III HD21 Trial By the German Hodgkin Study Group
34. Prognosis in Adult AML is Precisely Predicted by the Disc-Assay Using the Chemosensitivity-Index CI
35. Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial
36. Propagation of Hodgkin and Reed-Sternberg Cells
37. Biology, Staging and Treatment of Hodgkin’s Disease
38. Impact of bone marrow involvement on early positron emission tomography response and progression‐free survival in the HD18 trial for patients with advanced‐stage Hodgkin lymphoma
39. Impact of centralized diagnostic review on quality of initial staging in Hodgkin lymphoma: experience of the German Hodgkin Study Group
40. Treatment of Advanced-Stage Hodgkin Lymphoma
41. Phase 2 study of BACOPP (bleomycin, adriamycin, cyclophosphamide, vincristine, procarbazine, and prednisone) in older patients with Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG)
42. Low serum interleukin-2 receptor levels correlate with a good prognosis in patients with Hodgkin’s lymphoma
43. Lectin Activity as a Marker for Hodgkin Disease Cells
44. Immunologically Confirmed Disseminated, Asymptomatic Encephalitozoon cuniculi Infection of the Gastrointestinal Tract in a Patient with AIDS
45. Relation of Burkitt's Tumor-Associated Herpes-ytpe Virus to Infectious Mononucleosis
46. Effect of a Herpes Group Virus (EBV) on Growth of Peripheral Leukocyte Cultures
47. Non-Hodgkin lymphoma after treatment for classical Hodgkin lymphoma: a report from the German Hodgkin Study Group
48. Positron emission tomography has a high negative predictive value for progression or early relapse for patients with residual disease after first-line chemotherapy in advanced-stage Hodgkin lymphoma
49. The Unique Characteristics and Management of Patients Over 60 Years of Age with Classic Hodgkin Lymphoma
50. Genetic Evidence for Latent Septata intestinalis Infection in Human Immunodeficiency Virus-Infected Patients with Intestinal Microsporidiosis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.